|
Delaware
|
01-0616867
|
|||
|
(State or Other Jurisdiction of Incorporation)
|
(I.R.S. Employer Identification No.)
|
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
||
|
Common Stock, $0.001 par value
|
ERII
|
The Nasdaq Stock Market LLC
|
|
Page No.
|
||
|
Condensed Consolidated Balance Sheets - March 31, 2025 and December 31, 2024
|
||
|
Condensed Consolidated Statements of Operations - Three Months Ended March 31, 2025 and 2024
|
||
|
Condensed Consolidated Statements of Stockholders' Equity- Three Months Ended March 31, 2025 and 2024
|
||
|
Condensed Consolidated Statements of Cash Flows - Three Months Ended March 31, 2025 and 2024
|
||
|
Exhibit Index
|
||
|
•our belief that our PXoffers market-leading value with the highest technological and economic benefit;
|
|
•our belief that leveraging our pressure exchanger technology will unlock new commercial opportunities in the future;
|
|
•our belief that our PX G1300™can contribute to help make CO2-based refrigeration more economically viable in a broader
range of climates;
|
|
•our belief that our technology helps our customer achieve environmentally sustainable operations;
|
|
•our expectation that sales outside of the U.S.will remain a significant portion of our revenue;
|
|
•the scale of the environmental impact from the use of our solutions;
|
|
•the timing of our receipt of payment for products or services from our customers;
|
|
•our belief that our existing cash and cash equivalents, our short and/or long-term investments, and the ongoing cash generated
from our operations, will be sufficient to meet our anticipated liquidity needs for the foreseeable future, with the exception of a
decision to enter into an acquisition and/or fund investments in our latest technology arising from rapid market adoption that
could require us to seek additional equity or debt financing;
|
|
•our expectations relating to the amount and timing of recognized revenue from our projects;
|
|
•our expectation that we will continue to receive a tax benefit related to U.S. federal foreign-derived intangible income and
research and development tax credit;
|
|
•the outcome of proceedings, lawsuits, disputes and claims;
|
|
•the impact of losses due to indemnification obligations;
|
|
•other factors disclosed under the MD&A and Part I, Item 3, "Quantitative and Qualitative Disclosures about Market Risk," and
elsewhere in this Form 10-Q.
|
|
March 31,
2025
|
December 31,
2024
|
||
|
(In thousands)
|
|||
|
ASSETS
|
|||
|
Current assets:
|
|||
|
Cash and cash equivalents
|
$49,137
|
$29,627
|
|
|
Short-term investments
|
34,408
|
48,392
|
|
|
Accounts receivable, net
|
32,389
|
64,066
|
|
|
Inventories, net
|
32,410
|
24,906
|
|
|
Prepaid expenses and other assets
|
6,248
|
6,665
|
|
|
Total current assets
|
154,592
|
173,656
|
|
|
Long-term investments
|
23,185
|
21,832
|
|
|
Deferred tax assets, net
|
10,645
|
9,004
|
|
|
Property and equipment, net
|
14,585
|
15,424
|
|
|
Operating lease, right of use asset
|
9,168
|
9,695
|
|
|
Goodwill
|
12,790
|
12,790
|
|
|
Other assets, non-current
|
429
|
391
|
|
|
Total assets
|
$225,394
|
$242,792
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|||
|
Current liabilities:
|
|||
|
Accounts payable
|
$3,404
|
$3,109
|
|
|
Accrued expenses and other liabilities
|
11,272
|
17,728
|
|
|
Lease liabilities
|
2,357
|
2,020
|
|
|
Contract liabilities
|
1,401
|
571
|
|
|
Total current liabilities
|
18,434
|
23,428
|
|
|
Lease liabilities, non-current
|
8,751
|
9,297
|
|
|
Other liabilities, non-current
|
96
|
57
|
|
|
Total liabilities
|
27,281
|
32,782
|
|
|
Commitments and contingencies (Note 7)
|
|||
|
Stockholders' equity:
|
|||
|
Common stock
|
67
|
66
|
|
|
Additional paid-in capital
|
237,550
|
235,010
|
|
|
Accumulated other comprehensive income
|
75
|
98
|
|
|
Treasury stock
|
(135,405)
|
(130,870)
|
|
|
Retained earnings
|
95,826
|
105,706
|
|
|
Total stockholders' equity
|
198,113
|
210,010
|
|
|
Total liabilities and stockholders' equity
|
$225,394
|
$242,792
|
|
|
Three Months Ended March 31,
|
|||
|
2025
|
2024
|
||
|
|
(In thousands, except per share data)
|
||
|
Revenue
|
$8,065
|
$12,090
|
|
|
Cost of revenue
|
3,607
|
4,955
|
|
|
Gross profit
|
4,458
|
7,135
|
|
|
Operating expenses:
|
|||
|
General and administrative
|
8,574
|
7,566
|
|
|
Sales and marketing
|
4,906
|
6,152
|
|
|
Research and development
|
3,001
|
4,351
|
|
|
Restructuring charges
|
539
|
-
|
|
|
Total operating expenses
|
17,020
|
18,069
|
|
|
Loss from operations
|
(12,562)
|
(10,934)
|
|
|
Other income (expense):
|
|||
|
Interest income
|
1,073
|
1,442
|
|
|
Other non-operating income (expense), net
|
6
|
(53)
|
|
|
Total other income, net
|
1,079
|
1,389
|
|
|
Loss before income taxes
|
(11,483)
|
(9,545)
|
|
|
Benefit from income taxes
|
(1,603)
|
(1,285)
|
|
|
Net loss
|
$(9,880)
|
$(8,260)
|
|
|
Net loss per share:
|
|||
|
Basic
|
$ (0.18)
|
$ (0.14)
|
|
|
Diluted
|
$ (0.18)
|
$ (0.14)
|
|
|
Number of shares used in per share calculations:
|
|||
|
Basic and diluted
|
54,902
|
57,102
|
|
|
Three Months Ended March 31,
|
||||
|
2025
|
2024
|
|||
|
|
(In thousands)
|
|||
|
Net loss
|
$(9,880)
|
$(8,260)
|
||
|
Other comprehensive loss, net of tax
|
||||
|
Foreign currency translation adjustments
|
(16)
|
28
|
||
|
Unrealized loss on investments
|
(7)
|
(44)
|
||
|
Total other comprehensive loss, net of tax
|
(23)
|
(16)
|
||
|
Comprehensive loss
|
$(9,903)
|
$(8,276)
|
||
|
|
Three Months Ended March 31,
|
|||
|
|
2025
|
2024
|
||
|
|
(In thousands, except shares)
|
|||
|
Common stock
|
||||
|
Beginning balance
|
$66
|
$65
|
||
|
Issuance of common stock, net
|
1
|
-
|
||
|
Ending balance
|
67
|
65
|
||
|
Additional paid-in capital
|
||||
|
Beginning balance
|
235,010
|
217,617
|
||
|
Issuance of common stock, net
|
615
|
1,190
|
||
|
Stock-based compensation
|
1,925
|
3,315
|
||
|
Ending balance
|
237,550
|
222,122
|
||
|
Accumulated other comprehensive income (loss)
|
||||
|
Beginning balance
|
98
|
(44)
|
||
|
Other comprehensive loss
|
||||
|
Foreign currency translation adjustments
|
(16)
|
28
|
||
|
Unrealized loss on investments
|
(7)
|
(44)
|
||
|
Total other comprehensive loss, net
|
(23)
|
(16)
|
||
|
Ending balance
|
75
|
(60)
|
||
|
Treasury stock
|
||||
|
Beginning balance
|
(130,870)
|
(80,486)
|
||
|
Common stock repurchased
|
(4,535)
|
-
|
||
|
Ending balance
|
(135,405)
|
(80,486)
|
||
|
Retained earnings
|
||||
|
Beginning balance
|
105,706
|
82,656
|
||
|
Net loss
|
(9,880)
|
(8,260)
|
||
|
Ending balance
|
95,826
|
74,396
|
||
|
Total stockholders' equity
|
$198,113
|
$216,037
|
||
|
Common stock issued (shares)
|
||||
|
Beginning balance
|
66,182,906
|
65,029,459
|
||
|
Issuance of common stock, net
|
350,146
|
448,455
|
||
|
Ending balance
|
66,533,052
|
65,477,914
|
||
|
Treasury stock (shares)
|
||||
|
Beginning balance
|
11,397,045
|
8,148,512
|
||
|
Common stock repurchased
|
279,295
|
-
|
||
|
Ending balance
|
11,676,340
|
8,148,512
|
||
|
Total common stock outstanding (shares)
|
54,856,712
|
57,329,402
|
||
|
Three Months Ended March 31,
|
||||
|
2025
|
2024
|
|||
|
(In thousands)
|
||||
|
Cash flows from operating activities:
|
||||
|
Net loss
|
$(9,880)
|
$(8,260)
|
||
|
Adjustments to reconcile net loss to cash provided by operating activities
|
||||
|
Stock-based compensation
|
1,963
|
3,283
|
||
|
Depreciation and amortization
|
962
|
1,029
|
||
|
Right of use asset amortization
|
464
|
431
|
||
|
Accretion (amortization) of discounts (premiums) on investments
|
(231)
|
(231)
|
||
|
Deferred income taxes
|
(1,641)
|
(1,328)
|
||
|
Impairment of long-lived assets
|
353
|
-
|
||
|
Other non-cash adjustments
|
21
|
116
|
||
|
Changes in operating assets and liabilities:
|
||||
|
Accounts receivable, net
|
31,677
|
21,882
|
||
|
Contract assets
|
378
|
-
|
||
|
Inventories, net
|
(7,645)
|
(5,723)
|
||
|
Prepaid and other assets
|
(37)
|
(545)
|
||
|
Accounts payable
|
176
|
1,140
|
||
|
Accrued expenses and other liabilities
|
(6,712)
|
(7,589)
|
||
|
Contract liabilities
|
830
|
2,292
|
||
|
Net cash provided by operating activities
|
10,678
|
6,497
|
||
|
Cash flows from investing activities:
|
||||
|
Maturities of marketable securities
|
27,224
|
16,534
|
||
|
Purchases of marketable securities
|
(14,369)
|
(20,783)
|
||
|
Capital expenditures
|
(191)
|
(824)
|
||
|
Proceeds from sales of fixed assets
|
10
|
87
|
||
|
Net cash provided by (used in) investing activities
|
12,674
|
(4,986)
|
||
|
Cash flows from financing activities:
|
||||
|
Net proceeds from issuance of common stock
|
616
|
1,190
|
||
|
Repurchase of common stock
|
(4,490)
|
-
|
||
|
Net cash (used in) provided by financing activities
|
(3,874)
|
1,190
|
||
|
Effect of exchange rate differences on cash and cash equivalents
|
33
|
(19)
|
||
|
Net change in cash, cash equivalents and restricted cash
|
19,511
|
2,682
|
||
|
Cash, cash equivalents and restricted cash, beginning of year
|
29,757
|
68,225
|
||
|
Cash, cash equivalents and restricted cash, end of period
|
$49,268
|
$70,907
|
||
|
Three Months Ended March 31, 2025
|
Three Months Ended March 31, 2024
|
|||||||||||
|
Water
|
Emerging
Technologies
|
Total
|
Water
|
Emerging
Technologies
|
Total
|
|||||||
|
(In thousands)
|
||||||||||||
|
Geographical market
|
||||||||||||
|
Asia1
|
$3,438
|
$-
|
$3,438
|
$1,979
|
$-
|
$1,979
|
||||||
|
Middle East and Africa
|
2,880
|
1
|
2,881
|
4,785
|
1
|
4,786
|
||||||
|
Europe
|
1,075
|
-
|
1,075
|
1,386
|
-
|
1,386
|
||||||
|
Americas
|
671
|
-
|
671
|
3,939
|
-
|
3,939
|
||||||
|
Total revenue
|
$8,064
|
$1
|
$8,065
|
$12,089
|
$1
|
$12,090
|
||||||
|
Channel
|
||||||||||||
|
Aftermarket
|
$4,027
|
$1
|
$4,028
|
$4,643
|
$1
|
$4,644
|
||||||
|
Original equipment manufacturer
|
4,001
|
-
|
4,001
|
3,346
|
-
|
3,346
|
||||||
|
Megaproject
|
36
|
-
|
36
|
4,100
|
-
|
4,100
|
||||||
|
Total revenue
|
$8,064
|
$1
|
$8,065
|
$12,089
|
$1
|
$12,090
|
||||||
|
March 31,
2025
|
December 31,
2024
|
|||
|
(In thousands)
|
||||
|
Accounts receivable, net
|
$32,389
|
$64,066
|
||
|
Contract assets, current (included in prepaid expenses and other assets)
|
$2,398
|
$2,776
|
||
|
Contract liabilities:
|
||||
|
Contract liabilities, current
|
$1,401
|
$571
|
||
|
Total contract liabilities
|
$1,401
|
$571
|
||
|
March 31,
2025
|
December 31,
2024
|
||
|
(In thousands)
|
|||
|
Contract liabilities, beginning of year
|
$571
|
$1,187
|
|
|
Revenue recognized
|
(34)
|
(1,085)
|
|
|
Cash received, excluding amounts recognized as revenue during the period
|
864
|
469
|
|
|
Contract liabilities, end of period
|
$1,401
|
$571
|
|
|
Period
|
Remaining
Performance
Obligations
|
||
|
(In thousands)
|
|||
|
2025 (remaining nine months)
|
$5,101
|
||
|
2026
|
3,418
|
||
|
Total
|
$8,519
|
|
Three Months Ended March 31,
|
||||
|
2025
|
2024
|
|||
|
(In thousands, except per share amounts)
|
||||
|
Numerator
|
||||
|
Net loss
|
$(9,880)
|
$(8,260)
|
||
|
Denominator (weighted average shares)
|
||||
|
Basic and dilutive common shares outstanding
|
54,902
|
57,102
|
||
|
Net loss per share
|
||||
|
Basic
|
$ (0.18)
|
$ (0.14)
|
||
|
Diluted
|
$ (0.18)
|
$ (0.14)
|
||
|
|
Three Months Ended March 31,
|
||
|
|
2025
|
2024
|
|
|
(In thousands)
|
|||
|
Anti-dilutive equity award shares
|
2,806
|
3,286
|
|
|
March 31,
2025
|
December 31,
2024
|
||
|
(In thousands)
|
|||
|
Cash and cash equivalents
|
$49,137
|
$29,627
|
|
|
Restricted cash, non-current (included in other assets, non-current)
|
131
|
130
|
|
|
Total cash, cash equivalents and restricted cash
|
$49,268
|
$29,757
|
|
|
|
March 31,
2025
|
December 31,
2024
|
|
|
(In thousands)
|
|||
|
Accounts receivable, gross
|
$32,610
|
$64,287
|
|
|
Allowance for doubtful accounts
|
(221)
|
(221)
|
|
|
Accounts receivable, net
|
$32,389
|
$64,066
|
|
|
|
March 31,
2025
|
December 31,
2024
|
|
|
(In thousands)
|
|||
|
Raw materials
|
$9,644
|
$8,829
|
|
|
Work in process
|
8,054
|
6,417
|
|
|
Finished goods
|
15,582
|
10,463
|
|
|
Inventories, gross
|
33,280
|
25,709
|
|
|
Valuation adjustments for excess and obsolete inventory
|
(870)
|
(803)
|
|
|
Inventories, net
|
$32,410
|
$24,906
|
|
|
|
March 31,
2025
|
December 31,
2024
|
|
|
(In thousands)
|
|||
|
Accrued expenses and other liabilities, current
|
|||
|
Payroll, incentives and commissions payable
|
$4,932
|
$10,179
|
|
|
Warranty reserve
|
1,002
|
1,090
|
|
|
Restructuring accrual
|
1,029
|
2,476
|
|
|
Income taxes payable
|
958
|
947
|
|
|
Other accrued expenses and other liabilities
|
3,351
|
3,036
|
|
|
Total accrued expenses and other liabilities
|
11,272
|
17,728
|
|
|
Other liabilities, non-current
|
96
|
57
|
|
|
Total accrued expenses, and current and non-current other liabilities
|
$11,368
|
$17,785
|
|
|
|
Segment
|
Corporate
|
Total Expense
|
|||||
|
|
Water
|
Emerging
Technology
|
||||||
|
(In thousands)
|
||||||||
|
Amount recognized in 2024
|
1,147
|
832
|
497
|
2,476
|
||||
|
Amount recognized in 2025
|
210
|
123
|
206
|
539
|
||||
|
Total restructuring expenses recognized
|
$1,357
|
$955
|
$703
|
$3,015
|
||||
|
Severance and
Benefits
|
|
|
(In thousands)
|
|
|
Balance, as of December 31, 2024
|
$2,476
|
|
Restructuring provision
|
539
|
|
Cash paid
|
(1,986)
|
|
Balance, as of March 31, 2025
|
$1,029
|
|
March 31, 2025
|
December 31, 2024
|
||||||||||||||||
|
Pricing
Category
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Fair
Value
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Fair
Value
|
|||||||||
|
(In thousands)
|
|||||||||||||||||
|
Cash equivalents
|
|||||||||||||||||
|
Money market
securities
|
Level 1
|
$5,560
|
$-
|
$-
|
$5,560
|
$2,580
|
$-
|
$-
|
$2,580
|
||||||||
|
U.S. treasury
securities
|
Level 2
|
5,498
|
-
|
-
|
5,498
|
-
|
-
|
-
|
-
|
||||||||
|
Total cash equivalents
|
11,058
|
-
|
-
|
11,058
|
2,580
|
-
|
-
|
2,580
|
|||||||||
|
Short-term investments
|
|||||||||||||||||
|
U.S. treasury
securities
|
Level 2
|
17,380
|
17
|
-
|
17,397
|
20,303
|
42
|
-
|
20,345
|
||||||||
|
Corporate notes and
bonds
|
Level 2
|
16,970
|
41
|
-
|
17,011
|
27,995
|
52
|
-
|
28,047
|
||||||||
|
Total short-term investments
|
34,350
|
58
|
-
|
34,408
|
48,298
|
94
|
-
|
48,392
|
|||||||||
|
Long-term investments
|
|||||||||||||||||
|
U.S. treasury
securities
|
Level 2
|
3,510
|
13
|
-
|
3,523
|
999
|
1
|
-
|
1,000
|
||||||||
|
Corporate notes and
bonds
|
Level 2
|
14,598
|
66
|
-
|
14,664
|
18,983
|
65
|
(13)
|
19,035
|
||||||||
|
Municipal and
agency notes and
bonds
|
Level 2
|
4,999
|
-
|
(1)
|
4,998
|
1,799
|
-
|
(2)
|
1,797
|
||||||||
|
Total long-term investments
|
23,107
|
79
|
(1)
|
23,185
|
21,781
|
66
|
(15)
|
21,832
|
|||||||||
|
Total short and long-term
investments
|
57,457
|
137
|
(1)
|
57,593
|
70,079
|
160
|
(15)
|
70,224
|
|||||||||
|
Total
|
$68,515
|
$137
|
$(1)
|
$68,651
|
$72,659
|
$160
|
$(15)
|
$72,804
|
|||||||||
|
|
March 31, 2025
|
December 31, 2024
|
|||||
|
|
Fair
Value
|
Gross
Unrealized
Losses
|
Fair
Value
|
Gross
Unrealized
Losses
|
|||
|
(In thousands)
|
|||||||
|
Corporate notes and bonds
|
-
|
-
|
7,569
|
(13)
|
|||
|
Municipal and agency notes and bonds
|
3,997
|
(1)
|
1,797
|
(2)
|
|||
|
Total available-for-sale investments with unrealized loss positions
|
$3,997
|
$(1)
|
$9,366
|
$(15)
|
|||
|
March 31,
2025
|
December 31,
2024
|
||
|
(In thousands)
|
|||
|
Outstanding letters of credit
|
$15,675
|
$15,708
|
|
|
|
Three Months Ended March 31,
|
||
|
|
2025
|
2024
|
|
|
(In thousands, except percentages)
|
|||
|
Benefit from income taxes
|
$(1,603)
|
$(1,285)
|
|
|
Discrete items
|
52
|
76
|
|
|
Benefit from income taxes, excluding discrete items
|
$(1,551)
|
$(1,209)
|
|
|
Effective tax rate
|
14.0%
|
13.5%
|
|
|
Effective tax rate, excluding discrete items
|
13.5%
|
12.7%
|
|
|
Three Months Ended March 31, 2025
|
Three Months Ended March 31, 2024
|
||||||||||||||
|
Water
|
Emerging
Technologies
|
Corporate
|
Total
|
Water
|
Emerging
Technologies
|
Corporate
|
Total
|
||||||||
|
(In thousands)
|
|||||||||||||||
|
Revenue
|
$8,064
|
$1
|
$-
|
$8,065
|
$12,089
|
$1
|
$-
|
$12,090
|
|||||||
|
Cost of revenue
|
3,561
|
46
|
-
|
3,607
|
4,954
|
1
|
-
|
4,955
|
|||||||
|
Gross profit (loss)
|
4,503
|
(45)
|
-
|
4,458
|
7,135
|
-
|
-
|
7,135
|
|||||||
|
Operating expenses
|
|||||||||||||||
|
General and
administrative
|
1,573
|
755
|
6,246
|
8,574
|
1,922
|
1,018
|
4,626
|
7,566
|
|||||||
|
Sales and marketing
|
3,145
|
1,270
|
491
|
4,906
|
3,745
|
1,807
|
600
|
6,152
|
|||||||
|
Research and
development
|
1,178
|
1,823
|
-
|
3,001
|
1,100
|
3,251
|
-
|
4,351
|
|||||||
|
Restructuring charges
|
210
|
123
|
206
|
539
|
-
|
-
|
-
|
-
|
|||||||
|
Total operating
expenses
|
6,106
|
3,971
|
6,943
|
17,020
|
6,767
|
6,076
|
5,226
|
18,069
|
|||||||
|
Operating income (loss)
|
$(1,603)
|
$(4,016)
|
$(6,943)
|
$(12,562)
|
$368
|
$(6,076)
|
$(5,226)
|
$(10,934)
|
|||||||
|
Three Months Ended March 31,
|
||||||
|
|
Segment
|
2025
|
2024
|
|||
|
Customer A
|
Water
|
12%
|
**
|
|||
|
Customer B
|
Water
|
**
|
18%
|
|||
|
Customer C
|
Water
|
**
|
13%
|
|||
|
Number of Shares
Purchased
|
Average Price Paid
per Share(1)
|
Plan Activity
|
|||||
|
(In millions)
|
|||||||
|
February 2025 Authorization
|
$30.0
|
||||||
|
Repurchases under February 2025 Authorization
|
279,295
|
$16.07
|
(4.5)
|
||||
|
Remaining amount under February 2025 Authorization
|
$25.5
|
|
Three Months Ended March 31,
|
|||||||||||
|
2025
|
2024
|
||||||||||
|
Revenue
|
% of
Revenue
|
Revenue
|
% of
Revenue
|
Change
|
|||||||
|
(In thousands, except percentages)
|
|||||||||||
|
Aftermarket
|
$4,028
|
50%
|
$4,644
|
38%
|
$(616)
|
(13%)
|
|||||
|
Original equipment manufacturer
|
4,001
|
50%
|
3,346
|
28%
|
655
|
20%
|
|||||
|
Megaproject
|
36
|
-%
|
4,100
|
34%
|
(4,064)
|
(99%)
|
|||||
|
Total revenue
|
$8,065
|
100%
|
$12,090
|
100%
|
$(4,025)
|
(33%)
|
|||||
|
Three Months Ended March 31,
|
|||||||||||
|
2025
|
2024
|
||||||||||
|
Water
|
Emerging
Technologies
|
Total
|
Water
|
Emerging
Technologies
|
Total
|
||||||
|
(In thousands)
|
|||||||||||
|
Asia1
|
$3,438
|
$-
|
$3,438
|
$1,979
|
$-
|
$1,979
|
|||||
|
Middle East and Africa
|
2,880
|
1
|
2,881
|
4,785
|
1
|
4,786
|
|||||
|
Europe
|
1,075
|
-
|
1,075
|
1,386
|
-
|
1,386
|
|||||
|
Americas
|
671
|
-
|
671
|
3,939
|
-
|
3,939
|
|||||
|
Total revenue
|
$8,064
|
$1
|
$8,065
|
$12,089
|
$1
|
$12,090
|
|||||
|
|
Three Months Ended March 31,
|
||||
|
|
2025
|
2024
|
Change
|
||
|
(In thousands, except percentage and basis point)
|
|||||
|
Gross profit
|
$4,458
|
$7,135
|
$(2,677)
|
||
|
Gross margin
|
55.3%
|
59.0%
|
(370)bps
|
||
|
Three Months Ended March 31,
|
||||||||||||||||
|
2025
|
2024
|
|||||||||||||||
|
Water
|
Emerging
Technologies
|
Corporate
|
Total
|
Water
|
Emerging
Technologies
|
Corporate
|
Total
|
|||||||||
|
(In thousands)
|
||||||||||||||||
|
General and
administrative
|
$1,573
|
$755
|
$6,246
|
$8,574
|
$1,922
|
$1,018
|
$4,626
|
$7,566
|
||||||||
|
Sales and marketing
|
3,145
|
1,270
|
491
|
4,906
|
3,745
|
1,807
|
600
|
6,152
|
||||||||
|
Research and
development
|
1,178
|
1,823
|
-
|
3,001
|
1,100
|
3,251
|
-
|
4,351
|
||||||||
|
Restructuring charges
|
210
|
123
|
206
|
539
|
-
|
-
|
-
|
-
|
||||||||
|
Total operating
expenses
|
$6,106
|
$3,971
|
$6,943
|
$17,020
|
$6,767
|
$6,076
|
$5,226
|
$18,069
|
||||||||
|
|
Three Months Ended March 31,
|
||
|
|
2025
|
2024
|
|
|
(In thousands)
|
|||
|
Interest income
|
$1,073
|
$1,442
|
|
|
Other non-operating income (expense), net
|
6
|
(53)
|
|
|
Total other income, net
|
$1,079
|
$1,389
|
|
|
|
Three Months Ended March 31,
|
||
|
|
2025
|
2024
|
|
|
(In thousands, except percentages)
|
|||
|
Benefit from income taxes
|
$(1,603)
|
$(1,285)
|
|
|
Discrete items
|
52
|
76
|
|
|
Benefit from income taxes, excluding discrete items
|
$(1,551)
|
$(1,209)
|
|
|
Effective tax rate
|
14.0%
|
13.5%
|
|
|
Effective tax rate, excluding discrete items
|
13.5%
|
12.7%
|
|
|
Three Months Ended March 31,
|
|||||
|
2025
|
2024
|
Change
|
|||
|
|
(In thousands)
|
||||
|
Net cash provided by operating activities
|
$10,678
|
$6,497
|
$4,181
|
||
|
Net cash provided by (used in) investing activities
|
12,674
|
(4,986)
|
17,660
|
||
|
Net cash (used in) provided by financing activities
|
(3,874)
|
1,190
|
(5,064)
|
||
|
Effect of exchange rate differences on cash and cash equivalents
|
33
|
(19)
|
52
|
||
|
Net change in cash, cash equivalents and restricted cash
|
$19,511
|
$2,682
|
$16,829
|
||
|
Exhibit
Number
|
Exhibit Description
|
|
|
31.1*
|
||
|
31.2*
|
||
|
32.1**
|
||
|
101
|
Inline XBRL Document Set for the consolidated financial statements and accompanying notes in Part I, "Financial Information" of this
Quarterly Report on Form 10-Q.
|
|
|
104
|
Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.
|
|
|
ENERGY RECOVERY, INC.
|
||||
|
Date:
|
May 7, 2025
|
By:
|
/s/ DAVID W. MOON
|
||
|
David W. Moon
|
|||||
|
President and Chief Executive Officer
|
|||||
|
(Principal Executive Officer)
|
|||||
|
Date:
|
May 7, 2025
|
By:
|
/s/ MICHAEL S. MANCINI
|
||
|
Michael S. Mancini
|
|||||
|
Chief Financial Officer
|
|||||
|
(Principal Financial Officer)
|
|||||
Attachments
Disclaimer
ERI - Energy Recovery Inc. published this content on May 07, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 07, 2025 at 22:46 UTC.
